(Q40150712)

18 September 2017

title

The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma (English)

1 reference

18 September 2017

0 references

neoplastic invasiveness

1 reference

Young Eun Kwak

1

1 reference

18 September 2017

Nam Kyeoung Jeon

series ordinal

2

1 reference

18 September 2017

Jin Kim

series ordinal

3

1 reference

18 September 2017

Eun Ju Lee

series ordinal

4

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Annals of the New York Academy of Sciences

18 September 2017

published in

1 reference

18 September 2017

volume

1095

1 reference

18 September 2017

page(s)

99-112

1 reference

describes a project that uses

18 September 2017

YD-10B

0 references

cites work

Advances in chemoprevention of head and neck cancer

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

The myoepithelial cell differentiation of mucoepidermoid carcinoma in a collagen gel-based coculture model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1397.014

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1397.014

1 reference

18 September 2017

1 reference